|
SGMR2_RAT |
Tmem97 |
Sigma intracellular receptor 2 |
3.035e-44 |
0.37
|
SGMR1_HUMAN |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
9.585e-43 |
0.46
|
CP2J2_HUMAN |
CYP2J2 |
Cytochrome P450 2J2 |
1.902e-38 |
0.31
|
SC6A4_MOUSE |
Slc6a4 |
Sodium-dependent serotonin transporter |
5.218e-32 |
0.32
|
NPFF1_HUMAN |
NPFFR1 |
Neuropeptide FF receptor 1 |
2.973e-31 |
0.42
|
NK2R_RAT |
Tacr2 |
Substance-K receptor |
9.246e-31 |
0.35
|
NPFF2_HUMAN |
NPFFR2 |
Neuropeptide FF receptor 2 |
9.844e-31 |
0.42
|
SGMR1_CAVPO |
SIGMAR1 |
Sigma non-opioid intracellular receptor 1 |
7.363e-30 |
0.41
|
DRD2_MOUSE |
Drd2 |
D(2) dopamine receptor |
2.17e-26 |
0.39
|
5HT7R_MOUSE |
Htr7 |
5-hydroxytryptamine receptor 7 |
9.719e-24 |
0.29
|
SGMR1_RAT |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
9.817e-24 |
0.42
|
SGMR1_MOUSE |
Sigmar1 |
Sigma non-opioid intracellular receptor 1 |
1.858e-23 |
0.39
|
SC6A3_MOUSE |
Slc6a3 |
Sodium-dependent dopamine transporter |
9.414e-20 |
0.32
|
VMAT2_RAT |
Slc18a2 |
Synaptic vesicular amine transporter |
9.624e-20 |
0.38
|
NMD3A_RAT |
Grin3a |
Glutamate receptor ionotropic, NMDA 3A |
4.202e-19 |
0.29
|
EBPL_HUMAN |
EBPL |
Emopamil-binding protein-like |
4.43e-19 |
0.30
|
OPRM_RAT |
Oprm1 |
Mu-type opioid receptor |
2.239e-18 |
0.38
|
5HT2C_RAT |
Htr2c |
5-hydroxytryptamine receptor 2C |
4.376e-18 |
0.44
|
OPRD_HUMAN |
OPRD1 |
Delta-type opioid receptor |
4.725e-17 |
0.38
|
OPRM_HUMAN |
OPRM1 |
Mu-type opioid receptor |
1.11e-16 |
0.38
|
PA_I000X |
PA |
Polymerase acidic protein |
3.442e-15 |
0.29
|
OPRK_HUMAN |
OPRK1 |
Kappa-type opioid receptor |
3.397e-14 |
0.38
|
CASB_RAT |
Csn2 |
Beta-casein |
2.173e-13 |
0.29
|
5HT2A_RAT |
Htr2a |
5-hydroxytryptamine receptor 2A |
4.379e-13 |
0.46
|
Q98UH1_DANRE |
oprm1 |
Mu opioid receptor-like OR2 |
2.783e-11 |
0.30
|
CHLE_MOUSE |
Bche |
Cholinesterase |
6.913e-11 |
0.29
|
PCP_HUMAN |
PRCP |
Lysosomal Pro-X carboxypeptidase |
1.227e-10 |
0.33
|
DRD2_HUMAN |
DRD2 |
D(2) dopamine receptor |
1.328e-10 |
0.46
|
S12A5_RAT |
Slc12a5 |
Solute carrier family 12 member 5 |
1.366e-10 |
0.30
|
CCR5_HUMAN |
CCR5 |
C-C chemokine receptor type 5 |
4.313e-10 |
0.34
|
DRD2_RAT |
Drd2 |
D(2) dopamine receptor |
5.297e-10 |
0.38
|
GP183_MOUSE |
Gpr183 |
G-protein coupled receptor 183 |
6.403e-10 |
0.28
|
OPRK_CAVPO |
OPRK1 |
Kappa-type opioid receptor |
8.063e-10 |
0.38
|
DHCR7_HUMAN |
DHCR7 |
7-dehydrocholesterol reductase |
8.811e-10 |
0.28
|
AROK_HELPY |
aroK |
Shikimate kinase |
2.635e-09 |
0.29
|
Q8WSF8_APLCA |
|
Soluble acetylcholine receptor |
3.399e-09 |
0.30
|
HPPD_ARATH |
HPD |
4-hydroxyphenylpyruvate dioxygenase |
5.161e-09 |
0.28
|
ADA1A_RABIT |
ADRA1A |
Alpha-1A adrenergic receptor |
5.788e-09 |
0.37
|
NMDE2_RAT |
Grin2b |
Glutamate receptor ionotropic, NMDA 2B |
1.422e-08 |
0.38
|
PPCE_PIG |
PREP |
Prolyl endopeptidase |
1.725e-08 |
0.30
|
EST5_RAT |
|
Liver carboxylesterase B-1 |
1.813e-08 |
0.28
|
CAC1C_RAT |
Cacna1c |
Voltage-dependent L-type calcium channel subunit alpha-1C |
4.177e-08 |
0.32
|
OPRM_CAVPO |
OPRM1 |
Mu-type opioid receptor |
1.141e-07 |
0.38
|
CCR3_HUMAN |
CCR3 |
C-C chemokine receptor type 3 |
1.666e-07 |
0.38
|
HRH1_CAVPO |
HRH1 |
Histamine H1 receptor |
2.367e-07 |
0.30
|
PA_I34A1 |
PA |
Polymerase acidic protein |
4.97e-07 |
0.29
|
OPRD_RAT |
Oprd1 |
Delta-type opioid receptor |
1.226e-06 |
0.38
|
DRD4_HUMAN |
DRD4 |
D(4) dopamine receptor |
2.434e-06 |
0.36
|
FKB1A_RAT |
Fkbp1a |
Peptidyl-prolyl cis-trans isomerase FKBP1A |
2.587e-06 |
0.29
|
CASP5_HUMAN |
CASP5 |
Caspase-5 |
3.01e-06 |
0.31
|
5HT1A_HUMAN |
HTR1A |
5-hydroxytryptamine receptor 1A |
3.617e-06 |
0.39
|
C3TDZ2_ECOLX |
fabH |
3-oxoacyl-[acyl-carrier-protein] synthase 3 |
4.778e-06 |
0.32
|
HRH3_RAT |
Hrh3 |
Histamine H3 receptor |
5.305e-06 |
0.36
|
NMDE2_HUMAN |
GRIN2B |
Glutamate receptor ionotropic, NMDA 2B |
7.187e-06 |
0.31
|
NK2R_MESAU |
TACR2 |
Substance-K receptor |
7.535e-06 |
0.29
|
5HT2A_HUMAN |
HTR2A |
5-hydroxytryptamine receptor 2A |
8.7e-06 |
0.46
|